GENE ONLINE|News &
Opinion
Blog

Licensing
FDA Rejects BioMarin Pharmaceuticals’ Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A
2020-08-20
Spotlight: Celltrion Healthcare’s Remsima Expands to Multiple Medical Uses
2020-07-20
Kymera Inks US$ 150M Deal with Sanofi for Potential Rheumatoid Arthritis and Eczema Treatments
2020-07-12
CSL Behring to Tackle Hemophilia B Using UniQure’s Gene Therapy Program
2020-06-28
BMS, bluebird bio’s Investigational BCMA CAR-T Therapy Faces Regulatory Setback
2020-05-18
LEO Pharma Strikes Deal with Asian Firms to Develop Atopic Dermatitis & Allergic Asthma Drug
2020-04-17
Arrakis Signs Lucrative Deal with Roche to Develop RNA Targeting Small Molecules
2020-04-09
Kite Pharma Licences Teneobio’s Antibody Platform to Fight Multiple Myeloma
2020-04-03
Japan Grants Orphan Drug Designation to Lynparza for Germline BRCA-mutated Pancreatic Cancer
2020-03-25
Janssen Bags FDA Breakthrough Therapy Designation for Lung Cancer Drug
2020-03-12
FDA’s Advisory Committee Recommends Palforzia’s approval for Peanut Allergy Treatment
2019-09-27
1 5 6 7
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top